Key Insights

Highlights

Success Rate

98% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.9%

1 terminated out of 108 trials

Success Rate

97.9%

+11.3% vs benchmark

Late-Stage Pipeline

9%

10 trials in Phase 3/4

Results Transparency

4%

2 of 47 completed with results

Key Signals

2 with results98% success

Data Visualizations

Phase Distribution

103Total
Not Applicable (76)
Early P 1 (1)
P 1 (3)
P 2 (13)
P 3 (2)
P 4 (8)

Trial Status

Completed47
Unknown22
Not Yet Recruiting19
Recruiting10
Active Not Recruiting7
Withdrawn2

Trial Success Rate

97.9%

Benchmark: 86.6%

Based on 47 completed trials

Clinical Trials (108)

Showing 20 of 20 trials
NCT07850986Not ApplicableActive Not Recruiting

Pain Assessment Governing Partial or Full Pulpotomy of Immature Molars With Irreversible Pulpitis in Molar Incisor Hypomineralization

NCT06586775Not ApplicableCompletedPrimary

Outcome of Complete Pulpotomy in Healthy and Type 2 Diabetic Patients in Permanent Teeth With Irreversible Pulpitis

NCT07836686Not ApplicableCompleted

CLINICAL AND RADIOGRAPHIC SUCCESS OF MODIFIED LSTR TECHNIQUES IN PRIMARY SECOND MOLARS

NCT06194721Not ApplicableCompletedPrimary

The Effect of Intra-pulpal Anesthesia With Cryotherapy on Intra-operative Pain

NCT06194773Not ApplicableCompletedPrimary

The Effect of Totalfil and Neosealer Sealers on the Post-endodontic Pain

NCT07808684Not ApplicableRecruiting

Impact of Cross-Sectional Design in Single-File Rotary System on Apical Debris Extrusion

NCT05811403Not ApplicableCompletedPrimary

Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis

NCT07783217Not ApplicableActive Not RecruitingPrimary

Clinical and Radiographic Outcomes of Pulpotomy Versus Pulpectomy in Primary Molars With Symptomatic Irreversible Pulpitis

NCT06183203Not ApplicableWithdrawnPrimary

Treatment Outcomes of Pulpotomy vs. Pulpectomy in Vital Primary Molars With Symptomatic Irreversible Pulpitis

NCT06904781Not ApplicableRecruitingPrimary

Treatment Outcomes of Pulpotomy Versus Pulpectomy in Vital Primary Molars Diagnosed With Irreversible Pulpitis

NCT06149845Not ApplicableActive Not RecruitingPrimary

Pulpotomy in Vital Primary Molars Diagnosed With Symptomatic Irreversible Pulpitis

NCT06679075Not ApplicableCompletedPrimary

Clinical and Radiographic Evaluation of Propolis as a Hemostatic Agent in Full Pulpotomy of Mature Permanent Molars With Irreversible Pulpitis

NCT02417337Phase 2Completed

Efficacy of Different Drugs to Control Post Root Canal Treatment Pain

NCT07658742Completed

Biomarkers for Differentiating Reversible and Irreversible Pulpitis

NCT07702942Not ApplicableCompletedPrimary

Comparative Evaluation of NeoPUTTY and MTA Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis

NCT07679152Not ApplicableCompleted

Endodontic Success of Coronally Sealed Non-obturated Canals, Regeneration-based Canals

NCT06358833Not ApplicableCompleted

Comparison of Endodontic Postoperative Pain Using Different Irrigation Systems

NCT07630181Not ApplicableNot Yet RecruitingPrimary

Salvadora Persica-Zinc Oxide Versus MTA as Pulpotomy Agents in Mature Permanent Molars With Irreversible Pulpitis

NCT07610057Not ApplicableNot Yet RecruitingPrimary

R. Officinalis as Pulpotomy Agent in Permanent Teeth With Irreversible Pulpitis

NCT07565012Phase 4CompletedPrimary

Comparative Evaluation of Diclofenac Sodium and Ibuprofen for Post-Endodontic Pain Management

Scroll to load more

Research Network

Activity Timeline